The Saudi Arabia in-vitro diagnostics (IVD) market, holding its position as the largest IVD market in the GCC region. The market continues to expand steadily, supported by rising chronic and infectious disease burden, an aging population, and sustained government investment in healthcare infrastructure under Vision 2030. Saudi Arabia in-vitro diagnostics (IVD) market size reached USD 785.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,095.6 Million by 2034, exhibiting a growth rate (CAGR) of 3.65% during 2026-2034. Diagnostics represent only a small share of total healthcare spending, yet they remain critical in medical decision making and in reducing the overall burden of disease and healthcare expenditure across the Kingdom.

How AI is Reshaping the Future of Saudi Arabia In-Vitro Diagnostics Market?

·         AI-powered diagnostic platforms are enabling faster and more accurate interpretation of laboratory results, reducing turnaround time for critical tests such as infectious disease panels and cancer biomarker screening.

·         Machine learning algorithms integrated into hematology and clinical chemistry analyzers are helping laboratories flag abnormal results automatically, supporting earlier clinical intervention in hospital-based diagnostic centers.

·         AI-driven predictive analytics are being used by public health authorities to identify high-risk populations for chronic disease screening, improving resource allocation across the Kingdom's expanding network of diagnostic laboratories.

·         Automated, AI-enabled molecular diagnostics platforms are accelerating PCR-based infectious disease testing, a capability that gained significant traction across Saudi hospitals during large-scale disease surveillance efforts.

·         Companies are increasingly applying AI to point-of-care diagnostic devices, allowing remote and rural healthcare facilities to deliver lab-quality results without dependence on centralized testing infrastructure.

Grab a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-in-vitro-diagnostics-market/requestsample

Market Growth Factors

1- The Saudi Arabia IVD market is being driven by a rising burden of chronic and lifestyle-related diseases. The Kingdom has one of the highest obesity rates in the world, with around 36 percent of the total population classified as obese. Hypertension prevalence stands at approximately 29 percent among males and 24 percent among females, while diabetes affects nearly 19 percent of the adult population. These figures are pushing sustained demand for diagnostic testing across clinical chemistry, hematology, and immunoassay platforms used to monitor and manage such conditions.

2- An expanding elderly population is compounding this demand, as age-related conditions require more frequent monitoring through blood tests, cardiology panels, and oncology screening. Hospital-based centers currently hold the largest share of the end-user landscape, reflecting the concentration of advanced diagnostic infrastructure within major hospital networks across Riyadh, Jeddah, and the Eastern Province.

3- Government healthcare investment under Vision 2030 continues to accelerate market expansion. Rising healthcare expenditure, improving laboratory infrastructure, and public health initiatives focused on early disease detection are widening access to diagnostic services across both public and private healthcare systems. Regulatory oversight from the Saudi Food and Drug Authority is also encouraging global diagnostics manufacturers to expand local registrations and distribution partnerships within the Kingdom.

Market Segmentation

Application Insights:

• Infectious Diseases
• Diabetes
• Blood Test
• Nephrology
• Cardiology
• Oncology
• Autoimmune Diseases
• Others

Technology/Technique Insights:

• ELISA and CLIA
• PCR
• Rapid Test
• Fluorescence Immunoassays (FIA)
• In Situ Hybridization
• Others

End User Insights:

• Hospital-Based Centres
• Diagnostics Chains
• Standalone Centers
• Others

Competitive Landscape

The competitive landscape of the Saudi Arabia in-vitro diagnostics market features a mix of global diagnostics leaders and specialized technology providers, including Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Sysmex Corporation, BD, and bioMerieux, among others. Companies operating in the Kingdom continue to focus on strategic partnerships, local distribution agreements, and product innovation across immunochemistry, molecular diagnostics, hematology, microbiology, and clinical chemistry platforms to strengthen their market positioning.

Recent Development & News

·         March 2025: Industry reporting highlighted that hospital-based centers continue to dominate the end-user landscape of Saudi Arabia's IVD market, supported by rising investment in advanced laboratory infrastructure across major hospital networks.

·         May 2026: Market research noted that Saudi Arabia's healthcare transformation under Vision 2030 is accelerating diagnostic testing volumes, with rising chronic disease prevalence and preventive screening programs driving sustained demand across hospitals and diagnostic laboratories.

·         March 2026: Analysts observed continued expansion of molecular diagnostics and immunoassay platforms across the Kingdom, as diagnostics chains and standalone centers gain share by offering faster, more accessible testing options to patients outside traditional hospital settings.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302